Mankind Pharma has been assigned an ESG rating score of ’69’ by CFC Finlease Private Limited, a SEBI-registered ESG Rating Provider, according to an email intimation received on October 29, 2025. The company clarifies that it did not engage the rating provider, and the rating was independently assigned. The detailed ESG report is available for a fee.
ESG Rating Update
Mankind Pharma has received an Environmental, Social, and Governance (ESG) rating score of ’69’. This rating was communicated to the company via email on October 29, 2025.
Rating Provider Details
The ESG rating was assigned by CFC Finlease Private Limited (“ESG Rating Provider”), a SEBI-registered ESG Rating Provider. Mankind Pharma clarifies that they did not engage the rating provider for this specific rating, meaning the assessment was conducted independently.
Report Availability
While the rating score has been shared with Mankind Pharma, the complete ESG report is available only on a paid basis. More details can be found on the company’s website at www.mankindpharma.com.
Source: BSE
